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Edited by Judit Ova´diAbstract We have examined polyphenols as potential inhibitors
of UDP-glucose dehydrogenase (UGDH) activity. Gallic acid
and quercetin decreased speciﬁc activities of UGDH and inhib-
ited the proliferation of MCF-7 human breast cancer cells. Wes-
tern blot analysis showed that gallic acid and quercetin did not
aﬀect UGDH protein expression, suggesting that UGDH activ-
ity is inhibited by polyphenols at the post-translational level.
Kinetics studies using human UGDH revealed that gallic acid
was a non-competitive inhibitor with respect to UDP-glucose
and NAD+. In contrast, quercetin showed a competitive inhibi-
tion and a mixed-type inhibition with respect to UDP-glucose
and NAD+, respectively. These results indicate that gallic acid
and quercetin are eﬀective inhibitors of UGDH that exert strong
antiproliferative activity in breast cancer cells.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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UDP-glucose dehydrogenase (UGDH; EC 1.1.1.22) cata-
lyzes an NAD+-dependent two-step oxidation of UDP-glucose
to generate UDP-glucuronate [1–3]. UDP-glucuronate is an
essential precursor in the synthesis of glycosaminoglycans,
such as hyaluronan (HA), which have a profound eﬀect on cell
behavior and developmental processes [4]. Vigetti et al. [5]
showed that manipulation of UGDH expression levels in
Xenopus impacts the production of HA in a manner that de-
pends upon the availability of UDP-glucuronic acid. Increases
in UDP-glucuronic acid can also lead to excessive production
of proteoglycans, which have been implicated in the progres-
sion of epithelial cancers [6–9]. The up-regulation of UDP-glu-
curonosyltransferase 2B15 by estrogen and androgens in
estrogen-responsive breast cancer cells were proposed to repre-
sent a novel feedback mechanism on estrogen signaling or a
means of cross-talk between the androgen and estrogen signal-
ing pathways [10]. Interestingly, UGDH was identiﬁed in
breast cancer cells as a gene product dramatically up-regulatedAbbreviations: UGDH, UDP-glucose dehydrogenase
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doi:10.1016/j.febslet.2008.10.010in response to elevated androgen [11], so an androgen-secreting
organ such as the prostate may have a mechanism for in-
creased UGDH expression [12]. Thus, limiting UDP-glucu-
ronic acid availability in tumor cells by antagonizing UGDH
activity may represent a novel therapeutic strategy.
Our interest in the development of non-toxic compounds
that regulate UGDH activity has led us to examine the eﬀects
of polyphenols commonly found in fruit and vegetables. Diets
rich in polyphenols have shown antioxidative, anticarcino-
genic, atherosclerosis, antimutagenic and angiogenesis inhibi-
tor activities [13–15] and have been reported to exert
antiproliferative activity in cancer cell [16]. In this study, we
have tested the eﬀects of several polyphenols on UGDH activ-
ity and MCF-7 human breast cancer cell proliferation.2. Materials and methods
2.1. Cell culture
MCF-7 human breast carcinoma cells, used for all experiments, were
cultured in DMEM medium supplemented with 0.1 mg/mL insulin
(Sigma) and 10% FBS at 37 C in a humidiﬁed atmosphere of 5%
CO2 in air.2.2. Cell proliferation assay
Inhibition of cell proliferation by polyphenols was measured using
the MTT [3-(4,5-dimethylthiazolyl-2)-2,5-diphenylatetrazolium bro-
mide] reduction assay. MCF-7 cells were seeded in a 96-well plate at
a concentration of 2 · 104 cells/mL and changed to serum free medium
24 h prior to treatment. After 24 h incubation, cells were treated with
gallic acid, quercetin, syringic acid, kaempferol, salicylic acid, myrice-
tin, procatechuic acid, or trans-cinnamic acid for an additional 24 h.
During the last 4 h, cells were incubated with MTT stock solution.
Cells were then extracted with DMSO and absorbance was measured
at 580 nm. Morphological examinations were carried out after treating
with polyphenols for 24 h. This time point was chosen to facilitate the
observation of individual cell morphology in subconﬂuent cultures.
Cells were examined by phase contrast microscopy (Olympus I·71).2.3. Western blotting
Polyphenol-treated cells (1 · 106 cells/10 mL) were collected and
washed with phosphate-buﬀered saline (PBS). After centrifugation, ly-
sates from cells in 0.1 mL of PRO-PREP protein extraction solution
were incubated on ice with intermittent vortexing, followed by centri-
fugation at 14000 rpm for 20 min at 4 C. Equal amounts of total pro-
tein (50 lg) from each treatment group were diluted with loading
buﬀer, boiled and loaded onto 12% SDS–polyacrylamide gels. Samples
were electrophoresed and then transferred to a nitrocellulose mem-
brane for Western blotting using monoclonal antibodies against hUG-
DH as described before [2].blished by Elsevier B.V. All rights reserved.
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UGDH activity was measured in 100 mM sodium glycine, pH 8.7,
1 mM UDP-glucose at 25 C in the presence and absence of polyphe-
nols. The reaction was initiated by the addition of NAD+ at a ﬁnal
concentration of 1 mM. One unit of enzyme was deﬁned as the amount
of enzyme required to reduce 2 lmol of NAD+/min at pH 8.7 at room
temperature. Km and Vmax values of hUGDH in the presence of poly-
phenols were obtained from the initial velocity data and linear regres-
sion analysis of double-reciprocal plots; Ki values were calculated from
equations, as described elsewhere [17].2.5. Thermal stability studies
hUGDH thermal stability was assayed at 37 C using a 0.5 mg/mL
solution of puriﬁed hUGDH in 100 mM sodium glycine in the pres-
ence and absence of polyphenols. At various times, aliquots were with-
drawn into 100 mM sodium glycine, pH 8.7 containing 1 mM NAD+
and 1 mM UDP-glucose and the remaining activity was determined
by measuring absorbance at 340 nm.B
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Fig. 1. Growth inhibitory eﬀects of polyphenols on MCF-7 cells.
MCF-7 cells were treated with polyphenols for 24 h. (A) MTT assay in
gallic acid (j), quercetin (s), syringic acid (m), kaempferol (X),
salicylic acid (D), procatechuic acid (e), and trans-cinnamic acid (r).
(B) Phase contrast microscopic analysis of gallic acid- and quercetin-
treated MCF-7 cells. (1) Control cells; (2) cells treated with 300 lM
gallic acid; and (3) cells treated with 300 lM quercetin.3. Results and discussion
UGDH was shown to be dramatically up-regulated in breast
cancer cells in response to elevated androgen [11], suggesting
that other androgen-secreting organs, such as the prostate,
may increase UGDH expression by a similar mechanism
[12]. We have been interested in the development of non-toxic
compounds, including polyphenols, with regulatory activity
against UGDH activity. To investigate the eﬀects of polyphe-
nols on hUGDH in cells, we treated MCF-7 human breast car-
cinoma cells with various concentrations of the polyphenols
for 24 h. Of the seven polyphenols tested, only gallic acid
and quercetin showed prominent inhibitory eﬀects on human
breast cancer cell proliferation as determined by MTT viability
assays (Fig. 1A). Gallic acid reduced cell viability by 35% and
73% at 200 lM and 500 lM, respectively, whereas quercetin
reduced viability by 35% and 64% under the same conditions
(Fig. 1A). These results were reﬂected in the morphological
appearance of cells after 24 h exposure to gallic acid or querce-
tin. Gallic acid and quercetin had a marked eﬀect on morphol-
ogy at 300 lM, causing many cells to round up and become
more refractile under phase-contrast microscopy (Fig. 1B).
These results indicate that gallic acid and quercetin have
strong antiproliferative activity against human MCF-7 breast
cancer cells.
In addition to the antiproliferative eﬀects on MCF-7 cells
shown here, exposure of MCF-7 cells to quercetin for 24 h
has been previously shown to decrease cell protein content, de-
crease MTT reduction and alter cellular morphology [18].
Quercetin also exhibited antiproliferative eﬀects in other can-
cer cells [19] and has been shown to induce death by an apop-
totic mechanism in cancer cells [20–22]. In addition, quercetin
has been shown to regulate the growth of tumor cells through
the inhibition of protein kinases [23]. Granado-Serrano et al.
[24] have reported that quercetin induces a signiﬁcant time-
dependent inactivation of phosphatidylinositol 3-kinase, an
important eﬀector of the polyphosphoinositide pathway and
a key enzyme involved in signal transduction and cell transfor-
mation. Gallic acid, a naturally occurring plant polyphenol
with antioxidative activity, has been found to induce cell death
in promyelocytic leukemia HL-60RG cells and human colon
adenocarcinoma cells [25,26]. Polyphenols such as quercetin
may also have an indirect eﬀect on health because they are
metabolized by the same pathways as various xenobiotics orendogenous hormones [27]. For instance, quercetin is a better
substrate for catechol-O-methyl transferase than are its endog-
enous substrates, catecholamines and catechol estrogens [28].
Quercetin also may aﬀect the function of thyroid hormones,
steroids, and catecholamines by acting as an eﬃcient inhibitor
of sulfotransferases [29]. These results may suggest that poly-
phenols could aﬀect the bioavailability of many toxic chemi-
cals, and therapeutic drugs by aﬀecting the activities of
various enzymes involved in their own metabolism.
To investigate the relationship between antiproliferative ef-
fects and UGDH inhibition, we measured UGDH activity in
MCF-7 cells treated with polyphenols at various concentra-
tions. After treatment, the speciﬁc activity of UGDH was
determined in cleared lysates of washed cells. Of the seven
polyphenols tested, only gallic acid and quercetin showed
prominent inhibitory eﬀects on UGDH activity (Fig. 2A).
The speciﬁc activity in lysates of cells treated with 300 lM gal-
lic acid was 0.51 nmol/min/mg protein, a 66% reduction com-
pared to that of control lysates (1.50 nmol/min/mg protein;
Fig. 2A). Quercetin at the same concentration had a similar
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Fig. 2. Eﬀects of polyphenols on UGDH in MCF-7 cells. (A) Speciﬁc
activity of UGDH in crude extracts of cells was measured and
expressed as a percentage of control. Gallic acid (j), quercetin (s),
syringic acid (m), kaempferol (X), salicylic acid (D), procatechuic acid
(e), and trans-cinnamic acid (r). (B) UGDH expression levels
examined by Western blot.
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Fig. 3. Steady-state kinetic analysis of gallic acid eﬀects on hUGDH
activity. Puriﬁed hUGDH was incubated with gallic acid (0.5 mM and
1.0 mM) in 100 mM sodium glycine, pH 8.7 with (A) increasing
concentrations of UDP-glucose in the presence of 1 mM NAD+ or (B)
increasing concentrations of NAD+ in the presence of 1 mM UDP-
glucose.
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lysates to 0.61 nmol/min/mg protein (41% inhibition). To
verify that the inhibitory eﬀect was not due to a change in
UGDH expression, we performed Western blot analyses using
monoclonal antibodies against hUGDH [2]. Gallic acid and
quercetin treatment did not change the level of UGDH expres-
sion in MCF-7 cells (Fig. 2B), indicating that the inhibition of
UGDH activity by gallic acid and quercetin in cultured MCF-
7 cells was post-translational.
To further explore the mechanism of gallic acid- and querce-
tin-mediated inhibition of UGDH activity, we performed a
steady state kinetic analysis of puriﬁed human UGDH (hUG-
DH) in the presence of varying concentrations of gallic acid
and quercetin. In the absence of gallic acid and quercetin,
the Km values obtained for hUGDH were 17 lM for the sub-
strate, UDP-glucose, and 130 lM for the cofactor, NAD+
(Figs. 3 and 4). Both sets of conditions yielded a similar Vmax
of 156 nmol/min1/mg1 (Figs. 3 and 4). Kinetics studies per-
formed in the presence of polyphenols revealed that gallic acid
was a non-competitive inhibitor with respect to both UDP-glu-
cose (Fig. 3A) and NAD+ (Fig. 3B), with Ki values of 744 lM
and 1804 lM, respectively. In contrast, quercetin inhibited
hUGDH in a competitive manner with respect to UDP-glu-
cose (Fig. 4A) and with a mixed-type inhibition with respect
to NAD+ (Fig. 4B), exhibiting Ki values of 83 lM and
70 lM, respectively. The kinetic properties of hUGDH in thepresence and absence of gallic acid and quercetin are summa-
rized in Table 1.
Finally, we investigated whether gallic acid and quercetin re-
duced or negated the thermal stability of UGDH activity. In
the presence of gallic acid, the activity remaining after
30 min was 55% that of control, whereas only 20% of control
activity remained after incubating with quercetin (Fig. 5), indi-
cating that heat inactivation of hUGDH was accelerated to a
greater degree by quercetin than by gallic acid. Consistent with
the results of our kinetic analysis (Figs. 3 and 4), these data
suggest that gallic acid and quercetin act through diﬀerent
mechanisms to modulate hUGDH activity. The structure of
polyphenols varies from simple molecules to highly polymer-
ized compounds. These compounds contain a suﬃcient num-
ber of hydroxyls and carboxyls to form strong complexes
with proteins and other macromolecules [30]. Polyphenols also
have structures that are ideal for free radical-scavenging activ-
ities [31]. Although antioxidants generally have been consid-
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Fig. 4. Steady-state kinetic analysis quercetin eﬀects on hUGDH
activity. All conditions were the same as in Fig. 3 except incubating
hUGDH with quercetin (10 lM and 20 lM).
Table 1
Eﬀects of gallic acid and quercetin on hUGDH activity under steady-
state conditions. The data are expressed as mean ± S.D. of two
independent experiments.
Control Gallic
acid
Quercetin
Vmax-UDPG (nmol min
1 mg1) 156 ± 4 67 ± 2 160 ± 3
Vmax-NAD+ (nmol min
1 mg1) 155 ± 2 101 ± 3 38 ± 2
Km-UDPG (lM) 17 ± 1 18 ± 2 155 ± 4
Km-NAD+ (lM) 130 ± 3 135 ± 4 181 ± 2
Ki-UDPG (lM) 744 ± 2 83 ± 4
(Non-
competitive)
(Competitive)
Ki-NAD+ (lM) 1804 ± 4 70 ± 2
(Non-
competitive)
(Mixed type)
10 20 30
Time (min)
R
em
ai
ni
ng
 U
G
D
H
 a
ct
iv
ity
 
(%
 of
 co
ntr
ol)
0
100
75
50
25
gallic acid
quercetin
control
Fig. 5. Eﬀects of gallic acid and quercetin on hUGDH thermal
stability. Gallic acid or quercetin at 300 lM was incubated with
hUGDH in 100 mM sodium glycine, pH 7.0 37 C. At various times,
aliquots were withdrawn to measure the remaining activity.
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antioxidants may vary with diﬀerences in structure and dosage
[32].The concentrations of gallic acid and quercetin needed to
produce eﬀects on UGDH are at least 10-fold higher than
can be predicted to be reached under in vivo dietary condi-
tions. It is well known that the oral bioavailability of polyphe-
nols including gallic acid and quercetin is very low, producing
plasma concentrations most likely only 1/10th to 1/100th of
those necessary to produce an eﬀect. Most polyphenols cannot
be absorbed in their native form but undergo extensive meta-
bolic conjugation by methylation, sulfation, or glucuronida-
tion during absorption [27]. However, it is still not
understood if the polyphenols have to be in the free form to
exert their activity, or the conjugated polyphenols can exert
similar activity, as it has been reported for quercetin [33,34].
Therefore, extensive knowledge of the accumulation of physi-
ologic metabolites of gallic acid and quercetin in speciﬁc or-
gans is essential if their health eﬀects are to be understood.
In conclusion, our study demonstrated that gallic acid and
quercetin were capable of inhibiting UGDH activity and
reducing the viability of MCF-7 human breast cancer cells.
These results suggest the possibility that gallic acid and querce-
tin may modulate human breast cancer cell proliferation by
inhibiting UGDH. Further studies will be required, however,
to provide a detailed mechanism that deﬁnitively links these
properties.
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